Studienergebnisse DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies 23.12.2025 / 14:36 CET/CEST ...

Seasoned Biotech Entrepreneur Dr. Christian Thirion Appointed CEO of DiNATEQ AG and Group Chief Strategy & Business Development Officer; Dr. Josef El Andari Named Chief Scientific Officer of DiNAQOR ...

AI initiatives don’t stall because models aren’t good enough, but because data architecture lags the requirements of agentic systems.

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University's College ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

It’s the day the “Animal Goncourt” is awarded. “Who better,” a judge says, “to talk about the fabulous relationship between ...

Just because it’s cold doesn’t mean ticks are no longer a problem. The creature recently named pest of the year by the ...

VV169 saw complete clearance of disseminated myeloma tumors within 28 daysAnother dataset highlights Vyriad’s work in improved vector retargeting strategies in a comparative study of three methods for ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University’s College ...

Apple’s “App Intents” and Huawei’s “Intelligent Agent Framework” allow the OS to expose app functionalities as discrete ...

Authors explore complexities in scaling gene-therapy production with special attention is to monitoring and enhancing ...